1-4 of 4
Rebekka Grundler, PhD
Close
Sort by
Journal Articles

NPM-ALK Induces Tumour Development in a Murine Model of Anaplastic Large Cell Lymphoma (ALCL) Independently of Bcl-3 Expression.

Charlotte Gruber, MD, Rebekka Grundler, PhD, Georg Haecker, MD, Falco Fend, MD, Christian Peschel, MD, Justus Duyster, MD
Journal: Blood
Blood (2007) 110 (11): 460.
https://doi.org/10.1182/blood.V110.11.460.460
Published: 2007
Journal Articles

The Oncogenic Fusionprotein NPM-ALK Cooperates with Bcl2 To Induce T-Cell Lymphomas in Mice.

Cornelius Miething, MD, Rebekka Grundler, PhD, Claudia Mugler, Anette Bauer, Georg Häcker, MD, Christian Peschel, MD, Justus Duyster, MD
Journal: Blood
Blood (2006) 108 (11): 2058.
https://doi.org/10.1182/blood.V108.11.2058.2058
Published: 2006
Journal Articles

The Transcription Factors RUNX1/AML1 and RUNX3/AML2 Protect Bcr-Abl-Transformed B-Cells from Imatinib Induced Apoptosis.

Cornelius Miething, MD, Rebekka Grundler, PhD, Claudia Mugler, Heike Pfeifer, MD, Oliver Ottmann, MD, Simone Barwisch, Michael Speicher, PhD, Christian Peschel, MD, Justus Duyster, MD
Journal: Blood
Blood (2005) 106 (11): 540.
https://doi.org/10.1182/blood.V106.11.540.540
Published: 2005
Journal Articles

Interferon Regulatory Factor 4 Is Not Required for Induction of Chronic Myeloid Leukaemia-Like Myeloproliferative Disease by Bcr/Abl in Mice.

Anna Lena Illert, MD, Cornelius Miething, MD, Rebekka Grundler, PhD, Manuel Schmidt, PhD, Andreas Burchert, MD, Andreas Neubauer, MD, Claudia Mugler, Christian Peschel, MD, Justus Duyster, MD
Journal: Blood
Blood (2005) 106 (11): 2866.
https://doi.org/10.1182/blood.V106.11.2866.2866
Published: 2005